Clinical Trial Update: Investigational Therapeutics for the Treatment of People With Ebola Virus Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for investigational therapeutics in Ebola virus disease; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Virus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-09-08